16 and older, female only, with Immunization. Patients with the condition only — healthy volunteers not accepted.
Results — posted to ClinicalTrials.gov
Per-arm endpoint measurements with 95% confidence intervals where reported. Source: trial results section.
Number of Timely Vaccinations ReceivedPrimary· Up to 6 months after birth
Number of vaccinations received within 4 weeks of scheduled vaccination dates. Note: Vaccinations are due at birth and at ages 6, 10, and 14 weeks. Delays in 6 and/or 10 week vaccinations result in corresponding shifts in subsequent vaccination due dates. Timeliness is calculated independently for each vaccination in relation to its scheduled due date: The vaccination is considered timely if it is received within 4 weeks of the scheduled due date, not timely otherwise. Observations beyond 6 months after birth are censored.
Group
Value
95% CI
No Intervention
10
Reminders Only
5
Reminders + Conditional Financial Transfer
5
No Intervention
9
Reminders Only
6
Reminders + Conditional Financial Transfer
12
No Intervention
12
Reminders Only
6
Reminders + Conditional Financial Transfer
18
No Intervention
27
Reminders Only
12
Reminders + Conditional Financial Transfer
19
Number of Vaccinations ReceivedSecondary· Up to 6 months after birth
Number of vaccinations received (range 0-4, for the vaccination due at birth, 6, 10, and 14 weeks) Note: Vaccinations are due at birth and at ages 6, 10, and 14 weeks. Delays in 6 and/or 10 week vaccinations result in corresponding shifts in subsequent vaccination due dates. Thus, some vaccinations may be due after the end of the observation period, which ends 6 months after birth).
Group
Value
95% CI
No Intervention
0
Reminders Only
0
Reminders + Conditional Financial Transfer
0
No Intervention
0
Reminders Only
0
Reminders + Conditional Financial Transfer
0
No Intervention
1
Reminders Only
0
Reminders + Conditional Financial Transfer
0
No Intervention
11
Reminders Only
11
Reminders + Conditional Financial Transfer
5
Sponsor's own description
Vaccination is a cost-effective strategy for conferring immunity against a host of preventable diseases, however, rates of timely childhood vaccinations remain inadequate in resource-limited settings. We propose to evaluate the feasibility and efficacy of mHealth-assisted conditional cash transfers as a means of overcoming individual barriers to timely vaccinations. The study will form the basis for a pragmatic randomized controlled trial of the efficacy and cost-effectiveness of mHealth reminders and conditional cash transfers for improving rates of timely vaccinations among young children.
Publications & conference data
4 peer-reviewed publications reference this trial (live from Europe PMC):
NCT06300242 — Incentives for Influenza Vaccination
· NA
· completed
NCT06746090 — Improvement in Class II Molar Relationship Among Orthodontic Patients Reminded Through Text Message and Phone Call as Co
· NA
· completed
NCT05021224 — Engaging Suicidal Patients in Mental Health Treatment
· NA
· completed
NCT04147546 — Additional Screening With Sensitives RDTs and Malaria
· Phase 3
· completed
NCT05093309 — Preventing Opioid Overdose Deaths by Empowering Pharmacists to Dispense Naloxone
· NA
· completed
Other recruiting trials for Immunization
Currently open trials in the same condition.
NCT06718127 — Description of the Immune Response to Yellow Fever Vaccination
· NA
· recruiting
NCT05213000 — Adjuvant Effect of Physical Exercise on Immune Response to COVID-19 Vaccination and Interactions With Stress
· NA
· recruiting
Other Duke University trials
Trials by the same sponsor.
NCT07216456 — Vaginal Dilator Therapy After Pelvic Radiation
· NA
· not yet recruiting
NCT07519317 — Dosing and Deployment Trial: A Home-based Optokinetic Treatment
· NA
· not yet recruiting
NCT07275359 — Investigating Senolytic Properties in Pulmonary Rehabilitation and Metformin in COPD Exacerbations
· Phase 1
· not yet recruiting
NCT07216963 — The Community Paramedic Response and Overdose Outreach With Supportive Medical-Legal Services Study
· NA
· not yet recruiting
NCT07459218 — IDEAS for Hope to Reduce Suicide Risk and Improve HIV Care Engagement in Tanzania
· NA
· not yet recruiting
Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Duke University
Last refreshed: 7 March 2025
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03252288.